National Research (NRC) Competitors

National Research logo
$20.04 +0.55 (+2.82%)
As of 04:00 PM Eastern

NRC vs. STGW, GLOB, CNXC, FIVN, and BRAI

Should you buy National Research stock or one of its competitors? MarketBeat compares National Research with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with National Research include Stagwell (STGW), Globant (GLOB), Concentrix (CNXC), Five9 (FIVN), and Braiin (BRAI). These companies are all part of the "business services" industry.

How does National Research compare to Stagwell?

Stagwell (NASDAQ:STGW) and National Research (NASDAQ:NRC) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability and earnings.

Stagwell presently has a consensus target price of $7.65, suggesting a potential upside of 8.66%. National Research has a consensus target price of $23.00, suggesting a potential upside of 14.77%. Given National Research's stronger consensus rating and higher possible upside, analysts plainly believe National Research is more favorable than Stagwell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stagwell
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43
National Research
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, National Research had 1 more articles in the media than Stagwell. MarketBeat recorded 3 mentions for National Research and 2 mentions for Stagwell. National Research's average media sentiment score of 0.58 beat Stagwell's score of 0.00 indicating that National Research is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stagwell
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
National Research
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stagwell has higher revenue and earnings than National Research. National Research is trading at a lower price-to-earnings ratio than Stagwell, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stagwell$2.91B0.60$29.10M$0.07100.57
National Research$137.39M3.32$11.60M$0.3951.38

National Research has a net margin of 6.52% compared to Stagwell's net margin of 0.64%. National Research's return on equity of 122.73% beat Stagwell's return on equity.

Company Net Margins Return on Equity Return on Assets
Stagwell0.64% 24.12% 4.31%
National Research 6.52%122.73%14.18%

35.6% of Stagwell shares are owned by institutional investors. Comparatively, 47.3% of National Research shares are owned by institutional investors. 11.2% of Stagwell shares are owned by company insiders. Comparatively, 9.2% of National Research shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Stagwell has a beta of 1.29, indicating that its share price is 29% more volatile than the broader market. Comparatively, National Research has a beta of 0.37, indicating that its share price is 63% less volatile than the broader market.

Summary

National Research beats Stagwell on 10 of the 16 factors compared between the two stocks.

How does National Research compare to Globant?

Globant (NYSE:GLOB) and National Research (NASDAQ:NRC) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

Globant presently has a consensus target price of $64.81, suggesting a potential upside of 122.04%. National Research has a consensus target price of $23.00, suggesting a potential upside of 14.77%. Given Globant's higher possible upside, equities research analysts plainly believe Globant is more favorable than National Research.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Globant
1 Sell rating(s)
9 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.39
National Research
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

91.6% of Globant shares are held by institutional investors. Comparatively, 47.3% of National Research shares are held by institutional investors. 2.7% of Globant shares are held by insiders. Comparatively, 9.2% of National Research shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Globant has a beta of 1.02, suggesting that its stock price is 2% more volatile than the broader market. Comparatively, National Research has a beta of 0.37, suggesting that its stock price is 63% less volatile than the broader market.

In the previous week, Globant had 18 more articles in the media than National Research. MarketBeat recorded 21 mentions for Globant and 3 mentions for National Research. National Research's average media sentiment score of 0.58 beat Globant's score of 0.16 indicating that National Research is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Globant
1 Very Positive mention(s)
4 Positive mention(s)
15 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
National Research
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

National Research has a net margin of 6.52% compared to Globant's net margin of 4.46%. National Research's return on equity of 122.73% beat Globant's return on equity.

Company Net Margins Return on Equity Return on Assets
Globant4.46% 9.87% 6.51%
National Research 6.52%122.73%14.18%

Globant has higher revenue and earnings than National Research. Globant is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Globant$2.45B0.52$102.92M$2.4611.87
National Research$137.39M3.32$11.60M$0.3951.38

Summary

Globant and National Research tied by winning 8 of the 16 factors compared between the two stocks.

How does National Research compare to Concentrix?

National Research (NASDAQ:NRC) and Concentrix (NASDAQ:CNXC) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, analyst recommendations, risk, profitability and earnings.

National Research has a beta of 0.37, meaning that its stock price is 63% less volatile than the broader market. Comparatively, Concentrix has a beta of 0.44, meaning that its stock price is 56% less volatile than the broader market.

National Research currently has a consensus target price of $23.00, indicating a potential upside of 14.77%. Concentrix has a consensus target price of $48.50, indicating a potential upside of 99.26%. Given Concentrix's higher possible upside, analysts plainly believe Concentrix is more favorable than National Research.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Research
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Concentrix
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

National Research has a net margin of 6.52% compared to Concentrix's net margin of -13.35%. National Research's return on equity of 122.73% beat Concentrix's return on equity.

Company Net Margins Return on Equity Return on Assets
National Research6.52% 122.73% 14.18%
Concentrix -13.35%17.80%5.45%

National Research pays an annual dividend of $0.64 per share and has a dividend yield of 3.2%. Concentrix pays an annual dividend of $1.44 per share and has a dividend yield of 5.9%. National Research pays out 164.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Concentrix pays out -6.7% of its earnings in the form of a dividend. Concentrix has raised its dividend for 3 consecutive years. Concentrix is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

47.3% of National Research shares are owned by institutional investors. Comparatively, 90.3% of Concentrix shares are owned by institutional investors. 9.2% of National Research shares are owned by insiders. Comparatively, 0.9% of Concentrix shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

National Research has higher earnings, but lower revenue than Concentrix. Concentrix is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Research$137.39M3.32$11.60M$0.3951.38
Concentrix$9.83B0.15-$1.28B-$21.55N/A

In the previous week, Concentrix had 4 more articles in the media than National Research. MarketBeat recorded 7 mentions for Concentrix and 3 mentions for National Research. Concentrix's average media sentiment score of 0.65 beat National Research's score of 0.58 indicating that Concentrix is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Research
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Concentrix
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Concentrix beats National Research on 10 of the 19 factors compared between the two stocks.

How does National Research compare to Five9?

Five9 (NASDAQ:FIVN) and National Research (NASDAQ:NRC) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

National Research has a net margin of 6.52% compared to Five9's net margin of 4.87%. National Research's return on equity of 122.73% beat Five9's return on equity.

Company Net Margins Return on Equity Return on Assets
Five94.87% 12.66% 5.52%
National Research 6.52%122.73%14.18%

Five9 has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market. Comparatively, National Research has a beta of 0.37, indicating that its stock price is 63% less volatile than the broader market.

96.6% of Five9 shares are held by institutional investors. Comparatively, 47.3% of National Research shares are held by institutional investors. 1.2% of Five9 shares are held by insiders. Comparatively, 9.2% of National Research shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Five9 presently has a consensus target price of $25.93, indicating a potential upside of 36.04%. National Research has a consensus target price of $23.00, indicating a potential upside of 14.77%. Given Five9's higher possible upside, equities research analysts plainly believe Five9 is more favorable than National Research.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Five9
1 Sell rating(s)
7 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.50
National Research
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Five9 has higher revenue and earnings than National Research. Five9 is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Five9$1.15B1.27$39.42M$0.6628.88
National Research$137.39M3.32$11.60M$0.3951.38

In the previous week, Five9 had 4 more articles in the media than National Research. MarketBeat recorded 7 mentions for Five9 and 3 mentions for National Research. Five9's average media sentiment score of 0.65 beat National Research's score of 0.58 indicating that Five9 is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Five9
3 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
National Research
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Five9 beats National Research on 9 of the 15 factors compared between the two stocks.

How does National Research compare to Braiin?

Braiin (NASDAQ:BRAI) and National Research (NASDAQ:NRC) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

National Research has higher revenue and earnings than Braiin.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Braiin$73.41M19.54N/AN/AN/A
National Research$137.39M3.32$11.60M$0.3951.38

In the previous week, Braiin had 19 more articles in the media than National Research. MarketBeat recorded 22 mentions for Braiin and 3 mentions for National Research. National Research's average media sentiment score of 0.58 beat Braiin's score of 0.38 indicating that National Research is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Braiin
1 Very Positive mention(s)
8 Positive mention(s)
5 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Neutral
National Research
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

National Research has a net margin of 6.52% compared to Braiin's net margin of 0.00%. National Research's return on equity of 122.73% beat Braiin's return on equity.

Company Net Margins Return on Equity Return on Assets
BraiinN/A N/A N/A
National Research 6.52%122.73%14.18%

Braiin currently has a consensus price target of $10.00, indicating a potential upside of 43.68%. National Research has a consensus price target of $23.00, indicating a potential upside of 14.77%. Given Braiin's higher probable upside, equities research analysts clearly believe Braiin is more favorable than National Research.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Braiin
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
National Research
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

47.3% of National Research shares are owned by institutional investors. 47.9% of Braiin shares are owned by company insiders. Comparatively, 9.2% of National Research shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

National Research beats Braiin on 7 of the 11 factors compared between the two stocks.

Get National Research News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NRC vs. The Competition

MetricNational ResearchBUSINESS INFO SVC IndustryBusiness SectorNASDAQ Exchange
Market Cap$443.33M$16.71B$6.74B$12.39B
Dividend Yield3.28%1.80%3.23%5.83%
P/E Ratio51.3821.3722.7922.20
Price / Sales3.323.02394.39110.15
Price / Cash15.5013.2323.2054.51
Price / Book32.3213.485.686.50
Net Income$11.60M$644.38M$205.77M$336.88M
7 Day Performance8.50%-1.13%4.83%-0.22%
1 Month Performance5.03%-0.84%-0.39%0.77%
1 Year Performance17.88%-21.61%31.54%31.57%

National Research Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NRC
National Research
1.8903 of 5 stars
$20.04
+2.8%
$23.00
+14.8%
+17.8%$443.33M$137.39M51.38490
STGW
Stagwell
3.0622 of 5 stars
$6.86
+4.1%
$7.65
+11.5%
+49.7%$1.63B$2.91B98.0012,629
GLOB
Globant
4.3263 of 5 stars
$36.73
-0.4%
$64.81
+76.5%
-65.8%$1.62B$2.45B14.9328,773
CNXC
Concentrix
4.9242 of 5 stars
$26.62
+1.6%
$48.50
+82.2%
-52.3%$1.60B$9.83BN/A455,000
FIVN
Five9
4.9346 of 5 stars
$20.68
+0.1%
$25.93
+25.4%
-29.9%$1.58B$1.15B31.332,910

Related Companies and Tools


This page (NASDAQ:NRC) was last updated on 6/23/2026 by MarketBeat.com Staff.
From Our Partners